Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
Article excerpt
Highlighted: the sentence this signal was extracted from
SECAUCUS, N.J. , Oct. 22, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX ), a leading provider of diagnostic information services, today announced financial results for the third quarter ended September 30, 2026. "We delivered revenue growth of 10% and adjusted EPS growth of over 15% on continued strength across our physician, hospital and consumer channels, complemented by productivity gains from automation and AI," said Jim Davis, Chairman, CEO and President. "Our robust organic revenue growth demonstrates that our solutions are fulfilling the expanding clinical care needs of an aging population as well as the increasing number of people focused on prevention and wellness. With these growth trends and our strong performance, we are raising our revenue and EPS guidance for the full year." Recent Highlights: The company will hold its 2027 Investor Day on March 25, 2027, at the New York Stock Exchange. Additional information will be provided closer to the event. Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 Change 2026 2025 Change (dollars in millions, except per share data) Reported: Net revenues $ 3,097 $ 2,816 10.0 % $ 9,035 $ 8,229 9.8 % Diagnostic Information Services revenues $ 3,035 $ 2,755 10.2 % $ 8,845 $ 8,043 10.0 % Revenue per requisition (4.2) % (2.8) % Requisition volume 14.5 % 12.9 % Organic requisition volume 14.4 %...
Keep reading with a free account
The rest of this article, and every signal for Quest Diagnostics, is in your free account.
